To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.
Fulfillment of western medical diagnostic criteria requiring renal ischemia-reperfusion surgical operation and renal artery clamping time ≤ 30 min
Meets the criteria for Chinese medicine identification
18 ≤ age ≤ 65
Voluntary participation with signed informed consent
Patients with stage 4 or 5 renal insufficiency or patients with acute renal failure
Those with secondary factors such as systemic lupus erythematosus, drug-induced renal damage, etc. confirmed by examination
Does not meet the diagnosis of renal ischemia-reperfusion injury
Cases not within the scope of action of the drug